These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 7772054

  • 1. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y, Binner S, Nagase H.
    Biochem J; 1995 Jun 01; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [Abstract] [Full Text] [Related]

  • 2. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
    Ogata Y, Itoh Y, Nagase H.
    J Biol Chem; 1995 Aug 04; 270(31):18506-11. PubMed ID: 7629179
    [Abstract] [Full Text] [Related]

  • 3. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
    Nagase H, Suzuki K, Morodomi T, Enghild JJ, Salvesen G.
    Matrix Suppl; 1992 Aug 04; 1():237-44. PubMed ID: 1480033
    [Abstract] [Full Text] [Related]

  • 4. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y.
    Eur J Biochem; 1998 Apr 01; 253(1):67-75. PubMed ID: 9578462
    [Abstract] [Full Text] [Related]

  • 5. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS, Itoh Y, Young TN, Nagase H.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):163-9. PubMed ID: 8806767
    [Abstract] [Full Text] [Related]

  • 6. Activation of TIMP-2/progelatinase A complex by stromelysin.
    Miyazaki K, Umenishi F, Funahashi K, Koshikawa N, Yasumitsu H, Umeda M.
    Biochem Biophys Res Commun; 1992 Jun 30; 185(3):852-9. PubMed ID: 1320876
    [Abstract] [Full Text] [Related]

  • 7. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
    Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T.
    Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
    [Abstract] [Full Text] [Related]

  • 8. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 9. Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts.
    Stefansson S, Aimes RT, Seward NB, Alexander DS, Quigley JP.
    J Cell Physiol; 1994 Dec 15; 161(3):419-28. PubMed ID: 7962125
    [Abstract] [Full Text] [Related]

  • 10. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H.
    Biochem J; 1992 Jul 15; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, Okada Y.
    J Biol Chem; 1995 Mar 24; 270(12):6691-7. PubMed ID: 7896811
    [Abstract] [Full Text] [Related]

  • 12. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
    Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG.
    J Biol Chem; 1995 Mar 17; 270(11):6351-6. PubMed ID: 7890773
    [Abstract] [Full Text] [Related]

  • 13. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H.
    Biol Chem; 1997 Feb 17; 378(2):71-6. PubMed ID: 9088534
    [Abstract] [Full Text] [Related]

  • 14. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H, Atkinson SJ, Butler GS, Smith B, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17119-23. PubMed ID: 8663332
    [Abstract] [Full Text] [Related]

  • 15. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
    Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A.
    Gynecol Oncol; 2004 Jan 19; 92(1):47-56. PubMed ID: 14751137
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T.
    J Biol Chem; 1992 Oct 25; 267(30):21712-9. PubMed ID: 1400481
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
    Benbow U, Butticè G, Nagase H, Kurkinen M.
    J Biol Chem; 1996 May 03; 271(18):10715-22. PubMed ID: 8631880
    [Abstract] [Full Text] [Related]

  • 18. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 19. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
    Wang Z, Juttermann R, Soloway PD.
    J Biol Chem; 2000 Aug 25; 275(34):26411-5. PubMed ID: 10827175
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y.
    Carcinogenesis; 1999 Jul 25; 20(7):1323-9. PubMed ID: 10383907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.